77477-92-0

Basic information

• Product Name: Benzenecarbothioamide, 4-(heptyloxy)-
• CAS NO: 77477-92-0
• Molecular Formula: C14H21NOS
• Molecular Weight: 251.393
• Mol File: 77477-92-0.mol

Chemical Properties

• CAS DataBase Reference: Benzenecarbothioamide, 4-(heptyloxy)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenecarbothioamide, 4-(heptyloxy)-(77477-92-0)
• EPA Substance Registry System: Benzenecarbothioamide, 4-(heptyloxy)-(77477-92-0)

Safety Data

• Hazardous Substances Data: 77477-92-0(Hazardous Substances Data)

Upstream product

• 123732-04-7 4-n-heptyloxybromobenzene 
• 203116-01-2 4-(heptyloxy)benzamide 
• 29147-88-4 4-(heptyloxy)benzonitrile 

Downstream Products

• 77477-74-8 3,5-Bis-<4-heptyloxy-phenyl>-1,2,4-thiadiazol 
• 1443792-00-4 (S)-methyl 2-((tert-butoxycarbonyl)amino)-3-(4-(2-(4-(heptyloxy)phenyl)thiazol-4-yl)phenyl)propanoate 
• 1443791-99-8 4-(4-bromophenyl)-2-(4-(heptyloxy)phenyl)thiazole 

Relevant articles and documents

GLP-1 RECEPTOR MODULATORS

Compounds are provided that modulate the glucagon-like peptide 1 (GLP-1) receptor, as well as methods of their synthesis, and methods of their therapeutic and/or prophylactic use. Such compounds can act as modulators or potentiators of GLP-1 receptor on their own, or with incretin peptides such as GLP-1(7-36) and GLP-1(9-36), or with peptide-based therapies, such as exenatide and liraglutide, and have the following general structure (where "^^^^" represents either or both the R and S form of the compound) (I) where A, B, C, Y1, Y2, Z, R1, R2, R3, R4, R5, W1, n, p and q are as defined herein.

NOVEL GLP-1 RECEPTOR MODULATORS

Compounds are provided that modulate the glucagon-like peptide 1 (GLP-1) receptor, as well as methods of their synthesis, and methods of their therapeutic and/or prophylactic use. Such compounds can act as modulators or potentiators of GLP-1 receptor on their own, or with incretin peptides such as GLP-1(7-36) and GLP-1(9-36), or with peptide-based therapies, such as exenatide and liraglutide, and have the following general structure (where "()" represents either or both the R and S form of the compound): where A, B, C, Y1, Y2, Z, R1, R2, R3, R4, R5, W1, n, p and q are as defined herein.

NOVEL GLP-1 RECEPTOR MODULATORS

The invention relates to compounds that modulate the glucagon-like peptide 1 (GLP-1) receptor, methods of their synthesis, and methods of their therapeutic and/or prophylactic use. Such compounds are act as modulators or potentiators of GLP-1 receptor on their own, or with receptor ligands including GLP-1 peptides GLP-1(7-36) and GLP-1(9-36), or with peptide-based therapies, such as exenatide and liraglutide, and have the following general structure (where"﹋" represents either or both the R and S form of the compound): where A, B, C, Y1, Y2, Z, R1, R2, R3, R4, R5, W1, n, p and q are as defined herein.